BioInvent’s Licensing Agreement with Exelixis

Wiggin and Dana LLP represented BioInvent International AB on the license agreement with Exelixis, Inc. to develop novel antibody-based immuno-oncology therapies.The collaboration is intended to expand…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now